NCT00464542View on ClinicalTrials.gov

Asymptomatic Bacterial Vaginosis and Herpes Simplex Virus Type 2 (BV/HSV-2) Shedding Study

PHASE4CompletedINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

December 31, 2007

Primary Completion Date

March 31, 2010

Study Completion Date

March 31, 2010

Conditions
Bacterial Vaginosis
Interventions
DRUG

Metronidazole

500 mg, taken by mouth, two times a day, 7 days

Trial Locations (2)

15213

University of Pittsburgh, Pittsburgh

15237

University of Pittsburgh, Magee Womens Hospital, Pittsburgh

All Listed Sponsors
lead

University of Pittsburgh

OTHER

NCT00464542 - Asymptomatic Bacterial Vaginosis and Herpes Simplex Virus Type 2 (BV/HSV-2) Shedding Study | Biotech Hunter | Biotech Hunter